BMC Cancer 2009, 9:182 http://www.biomedcentral.com/1471-2407/9/182 17. The Endogenous Hormones and Breast Cancer Collaborative Group: Endogenous sex hormones and breast cancer in postmeno- pausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002, 94:606-616. 18. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, et al.: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002, 288:321-333. 19. Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G: Postmenopausal hormone therapy and change in mam- mographic density. J Natl Cancer Inst 2003, 95:30-37. 20. Greendale GA, Palla SL, Ursin G, Laughlin GA, Crandall C, Pike MC, Reboussin BA: The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Inter- ventions Mammographic Density Study. Am J Epidemiol 2005, 162:826-834. 21. Boyd NF, Stone J, Martin LJ, Jong R, Fishell E, Yaffe M, Hammond G, Minkin S: The association of breast mitogens with mammo- graphic densities. Br J Cancer 2002, 87:876-882. 22. Tamimi RM, Byrne C, Colditz GA, Hankinson SE: Endogenous hor- mone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2007, 99:1178-1187. 23. Verheus M, Peeters PH, Van Noord PA, Schouw YT van der, Grobbee DE, van Gils CH: No relationship between circulating levels of sex steroids and mammographic breast density: the Pros- pect-EPIC cohort. Breast Cancer Res 2007, 9:R53. 24. Noh JJ, Maskarinec G, Pagano I, Cheung LW, Stanczyk FZ: Mammo- graphic densities and circulating hormones: a cross-sectional study in premenopausal women. Breast 2006, 15:20-28. 25. Barkhem T, Carlsson B, Nilsson Y, Enmark E, Gustafsson J, Nilsson S: Differential response of estrogen receptor alpha and estro- gen receptor beta to partial estrogen agonists/antagonists. Mol Pharmacol 1998, 54:105-112. 26. Fox EM, Davis RJ, Shupnik MA: ERbeta in breast cancer– onlooker, passive player, or active protector? Steroids 2008, 73:1039-1051. 27. Gao X, Loggie BW, Nawaz Z: The roles of sex steroid receptor coregulators in cancer. Mol Cancer 2002, 1:7. 28. Gao X, Nawaz Z: Progesterone receptors – animal models and cell signaling in breast cancer: Role of steroid receptor coac- tivators and corepressors of progesterone receptors in breast cancer. Breast Cancer Res 2002, 4:182-186. 29. Nardulli AM, Greene GL, O'Malley BW, Katzenellenbogen BS: Reg- ulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: analysis of estrogen's effect on progesterone receptor synthesis and degradation. Endocrinology 1988, 122:935-944. 30. Leonardi E, Girlando S, Serio G, Mauri FA, Perrone G, Scampini S, Dalla PP, Barbareschi M: PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables. J Clin Pathol 1992, 45:416-419. 31. Ursin G, Hovanessian-Larsen L, Parisky YR, Pike MC, Wu AH: Greatly increased occurrence of breast cancers in areas of mammographically dense tissue. Breast Cancer Res 2005, 7:R605-R608. 32. Kolonel LN, Henderson BE, Hankin JH, Nomura AMY, Wilkens LR, Pike MC, Stram DO, Monroe KR, Earle ME, Nagamine FS: A multi- ethnic cohort in Hawaii and Los Angeles: baseline character- istics. Am J Epidemiol 2000, 151:346-357. 33. Maskarinec G, Pagano I, Lurie G, Wilkens LR, Kolonel LN: Mammo- graphic Density and Breast Cancer Risk: The Multiethnic Cohort. Am J Epidemiol 2005, 162:743-752. 34. Goodman MT, Hernandez BY, Hewitt S, Lynch CF, Cote TR, Frierson HF Jr, Moskaluk CA, Killeen JL, Cozen W, Key CR, et al.: Tissues from population-based cancer registries: a novel approach to increasing research potential. Hum Pathol 2005, 36:812-820. 35. Anderson WF, Luo S, Chatterjee N, Rosenberg PS, Matsuno RK, Goodman MT, Hernandez BY, Reichman M, Dolled-Filhart MP, O'Regan RM, et al.: Human epidermal growth factor receptor- 2 and estrogen receptor expression, a demonstration project using the residual tissue repository of the Surveil- lance, Epidemiology, and End Results (SEER) program. Breast Cancer Res Treat 2009, 113:189-196. 36. Shi SR, Key ME, Kalra KL: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991, 39:741-748. 37. Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ: The quantitative analysis of mammographic densities. Phys Med Biol 1994, 39:1629-1638. 38. Maskarinec G, Nagata C, Shimizu H, Kashiki Y: Comparison of mammographic densities and their determinants in women from Japan and Hawaii. Int J Cancer 2002, 102:29-33. 39. Maskarinec G, Pagano I, Chen Z, Nagata C, Gram IT: Ethnic and geographic differences in mammographic density and their association with breast cancer incidence. Breast Cancer Res Treat 2007, 104:47-56. 40. Simpson ER: Sources of estrogen and their importance. J Ster- oid Biochem Mol Biol 2003, 86:225-230. 41. Huang Y, Nagamani M, Anderson KE, Kurosky A, Haag AM, Grady JJ, Lu LJ: A strong association between body fat mass and pro- tein profiles in nipple aspirate fluid of healthy premenopau- sal non-lactating women. Breast Cancer Res Treat 2007, 104:57-66. 42. Yang XR, Charette LA, Garcia-Closas M, Lissowska J, Paal E, Sidawy M, Hewitt SM, Rimm DL, Sherman ME: Construction and valida- tion of tissue microarrays of ductal carcinoma in situ and ter- minal duct lobular units associated with invasive breast carcinoma. Diagn Mol Pathol 2006, 15:157-161. 43. Henriksen KL, Rasmussen BB, Lykkesfeldt AE, Moller S, Ejlertsen B, Mouridsen HT: Semi-quantitative scoring of potentially pre- dictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays. J Clin Pathol 2007, 60:397-404. 44. Stuedal A, Ma H, Bernstein L, Pike MC, Ursin G: Does breast size modify the association between mammographic density and breast cancer risk? Cancer Epidemiol Biomarkers Prev 2008, 17:621-627. 45. Bright RA, Morrison AS, Brisson J, Burstein NA, Sadowsky NS, Kopans DB, Meyer JE: Relationship between mammographic and histologic features of breast tissue in women with benign biopsies. Cancer 1988, 61:266-271. 46. Boyd NF, Jensen HM, Cooke G, Han HL, Lockwood GA, Miller AB: Mammographic densities and the prevalence and incidence of histological types of benign breast disease. Reference Pathologists of the Canadian National Breast Screening Study. Eur J Cancer Prev 2000, 9:15-24. Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2407/9/182/pre pub Publish with Bio Med Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical research in our lifetime." Sir Paul Nurse, Cancer Research UK Your research papers will be: available free of charge to the entire biomedical community peer reviewed and published immediately upon acceptance cited in PubMed and archived on PubMed Central yours — you keep the copyright Submit your manuscript here: http://www.biomedcentral.com/info/publishing_adv.asp BioMedcentral Page 8 of 8 (page number not for citation purposes)